Each marker below carries its technical name, what it measures in plain language, the limits of what it can tell you, and the nutrients known to move it. Where a framework and mainstream practice disagree, both views are shown rather than one being hidden.
Antinuclear Antibodies (ANA) -- Titer and Pattern
A screen for antibodies that bind components of the cell nucleus. It's the single most common first-line test when autoimmune disease is suspected, run by immunofluorescence (titer = how dilute the serum can be and still show binding; pattern = what part of the nucleus lights up).
Nutrients that move it
- Vitamin Demerging -- the VITAL trial (25,871 participants) found vitamin D supplementation (2,000 IU/day) reduced incident autoimmune disease diagnoses by 22% over about 5.3 years; this is a population-level incidence-reduction finding, not proof that vitamin D lowers an already-positive ANA titer in someone with existing disease. (cite: Hahn J et al., BMJ, 2022, PMID 35082139)
Food first: There's no dietary intervention proven to reverse a positive ANA. Vitamin D sufficiency and an anti-inflammatory dietary pattern are reasonable supportive measures, not a treatment for a positive screen.
When to see someone: A positive ANA is read alongside symptoms and other labs, never alone -- a low-titer positive with no symptoms is common in healthy people and usually not actionable. The titer and the pattern both carry information the raw positive/negative does not.
Read the studies on Antinuclear Antibodies (ANA) -- Titer and PatternErythrocyte Sedimentation Rate (ESR)
Cellular Six: MaintainThis marker sits in Maintain -- the cleanup and defence system, and whether it is switched on.
An old, nonspecific inflammation marker -- how fast red blood cells settle in a tube over an hour. Elevated fibrinogen and other acute-phase proteins during inflammation make cells clump and fall faster.
Food first: Correct underlying anemia (iron, B12, folate as appropriate), weight management, Mediterranean-pattern eating, smoking cessation -- the same broad levers that move CRP.
When to see someone: ESR rises with acute infection, recent surgery/dental work, pregnancy, and simple aging -- a single elevated reading isn't diagnostic of autoimmune disease without other supporting findings.
Read the studies on Erythrocyte Sedimentation Rate (ESR)High-Sensitivity C-Reactive Protein (hs-CRP)
Cellular Six: MaintainThis marker sits in Maintain -- the cleanup and defence system, and whether it is switched on.
A liver-produced acute-phase inflammation marker; more specific and faster-responding than ESR, widely used both in cardiology risk assessment and as a rough gauge of systemic inflammatory burden in autoimmune disease.
Food first: Mediterranean-pattern eating, weight loss if overweight, smoking cessation.
When to see someone: In lupus specifically CRP is unreliable as a flare marker -- it can sit normal during active disease unless infection or serositis is also present, so a normal CRP does not rule out activity. Curcumin has a real interaction with blood thinners.
Read the studies on High-Sensitivity C-Reactive Protein (hs-CRP)Complement C3 and C4
Two proteins of the complement immune cascade; in lupus specifically, immune complexes consume (use up) complement during active disease, so falling C3/C4 alongside rising anti-dsDNA is a classic (though imperfect) signal of a lupus flare, particularly lupus nephritis.
Nutrients that move it
- Curcuminemerging -- a randomized trial in lupus nephritis patients (44 subjects, 1,000 mg/day curcumin added to standard immunotherapy for 12 weeks) found significantly improved complement C3 and reduced serum NLRP3 inflammasome activity compared with standard therapy alone; this is a real RCT but small, short, and specific to lupus nephritis on top of standard treatment, not a general "complement booster." (cite: RCT, European Journal of Nutrition, 2024, curcumin/lupus nephritis)
- Vitamin Demerging -- a 2022 meta-analysis of 6 RCTs (276 SLE patients) found vitamin D supplementation improved C3/C4 levels alongside reduced SLEDAI disease-activity scores in some pooled analyses, though effects on anti-dsDNA positivity specifically were inconsistent across different meta-analyses of the same literature. (cite: systematic review/meta-analysis of RCTs, 2022, 6 trials/276 SLE patients)
Food first: There is no dietary or supplement intervention proven to normalize complement levels independent of treating the underlying disease activity; curcumin and vitamin D are reasonable adjuncts to discuss with a rheumatologist, not substitutes for standard lupus management.
When to see someone: Low complement always needs clinical correlation, especially a check for kidney involvement (urinalysis, proteinuria) -- this is not a marker to try to move with supplements without the treating rheumatologist involved.
Read the studies on Complement C3 and C4Rheumatoid Factor (RF)
An antibody (usually IgM) directed against the Fc portion of IgG; associated with rheumatoid arthritis but also positive in Sjogren's syndrome, some infections, and a meaningful share of healthy older adults, so it's neither sensitive nor specific enough to diagnose RA alone.
Nutrients that move it
- Omega-3 fatty acidsemerging -- in the SERA cohort (people at risk for future RA due to family history or genetic susceptibility), higher red-blood-cell omega-3 levels and omega-3 supplement use were associated with a significantly lower prevalence of RF positivity in people who carry the "shared epitope" genetic risk factor (OR 0.32), with a similar but non-significant trend for anti-CCP. This is a prevention/at-risk-population finding, not evidence that omega-3 lowers RF in someone who already has established RA. (cite: Gan RW et al., Annals of the Rheumatic Diseases, 2017, PMC5371398)
- Vitamin Demerging -- VITAL trial found reduced incident autoimmune disease broadly, including rheumatoid arthritis as one of the confirmed conditions in the trial's autoimmune disease composite. (cite: Hahn J et al., BMJ, 2022, PMID 35082139)
Food first: Omega-3 intake (fatty fish or algae-based supplement) and vitamin D sufficiency have the best prevention-stage evidence, particularly in people genetically predisposed to RA; neither is proven to reverse an established positive RF.
When to see someone: RF alone doesn't diagnose RA -- a positive RF in someone without joint symptoms is common and not automatically actionable; interpret alongside anti-CCP and clinical exam.
Read the studies on Rheumatoid Factor (RF)Anti-Cyclic Citrullinated Peptide (Anti-CCP / ACPA)
Antibodies against citrullinated proteins; more specific for rheumatoid arthritis than RF, and can appear years before clinical joint symptoms develop, making it useful both for diagnosis and for identifying at-risk individuals.
Nutrients that move it
- Omega-3 fatty acidsemerging -- the same SERA cohort work found omega-3 biomarkers/supplement use associated with a lower prevalence of anti-CCP positivity and lower rates of progression to inflammatory arthritis in anti-CCP-positive, at-risk individuals, with docosapentaenoic acid specifically linked to reduced risk of progression. (cite: Gan RW et al., Annals of the Rheumatic Diseases, 2017, PMC5371398; related cohort analysis, Rheumatology, 2017)
- Omega-3 in established RAcontested -- meta-analyses in diagnosed RA patients on standard therapy show mixed effects on overall disease activity; a 2024 meta-analysis of 18 RCTs (1,018 RA patients) found mixed effects on inflammation and disease activity, not a consistent antibody-lowering effect. (cite: meta-analysis, Clinical Rheumatology, 2024)
Food first: Same as RF -- omega-3 and vitamin D sufficiency are the most evidence-backed levers, strongest in prevention-stage/at-risk populations rather than in reversing established disease.
When to see someone: A positive anti-CCP in an asymptomatic person with a family history of RA is a meaningful risk signal worth discussing with a rheumatologist for monitoring -- it is not something to try to "treat away" with supplements alone.
Read the studies on Anti-Cyclic Citrullinated Peptide (Anti-CCP / ACPA)IgG, IgA, IgM (Total, Quantitative)
The three major immunoglobulin classes measured together as a quantitative immune-function panel -- IgG is the dominant long-term/memory antibody class, IgA is the primary mucosal-surface antibody (gut, respiratory tract), IgM is the first-responder antibody made early in an immune response.
Nutrients that move it
- Zincemerging -- zinc is required for normal lymphocyte development and antibody production; a randomized trial in children with persistent diarrhea found zinc supplementation altered serum IgA and IgA-IgG immune complex levels compared with controls, though effects on IgG and IgM specifically were not significant in that trial. Separately, zinc-deficient mice show reduced mucosal and serum IgA production, and dietary zinc has been shown to modify the course of IgA nephropathy in observational/mechanistic work -- consistent evidence that zinc status affects IgA specifically, less clear for IgG/IgM in replete adults. (cite: zinc/IgA-IgG complex RCT in children with persistent diarrhea; zinc/vitamin-A-deficient mice and mucosal IgA, PMC4440024; dietary zinc and IgA nephropathy, PMID 24587392)
- Vitamin Aemerging -- vitamin A (as retinoic acid) supports normal mucosal IgA production; combined vitamin-A-and-zinc deficiency in animal models produced lower serum and mucosal IgA than either deficiency alone, suggesting the two nutrients act together on mucosal antibody production. (cite: PMC4440024)
Food first: Correcting a confirmed zinc or vitamin A deficiency is the evidence-based lever; there is no good evidence that supplementing zinc or vitamin A above sufficiency raises immunoglobulin levels further in a replete, healthy person.
When to see someone: Selective IgA deficiency needs to be flagged before ordering celiac serology (see below), since it causes false-negative tTG-IgA results, and rarely carries a risk of severe transfusion/blood-product reactions -- this should be documented in a patient's chart if identified. Never chase a "low-normal" immunoglobulin number with high-dose supplements without an immunology workup if genuinely deficient.
Read the studies on IgG, IgA, IgM (Total, Quantitative)IgG Subclasses (IgG1-IgG4)
A breakdown of total IgG into its four subclasses; ordered when someone has recurrent infections despite a normal total IgG, since a subclass can be selectively low even when the sum looks normal.
Food first: General immune-supportive nutrition (adequate protein, zinc, vitamin D) is reasonable background care, but a clinically significant IgG subclass deficiency is managed by immunology, sometimes with immunoglobulin replacement therapy, not diet.
When to see someone: Don't over-interpret an isolated low IgG subclass without a clinical history of recurrent infection -- many people with a "low" subclass on paper are asymptomatic and need no treatment.
Read the studies on IgG Subclasses (IgG1-IgG4)Immunoglobulin E (IgE), Total and Allergen-Specific
The antibody class responsible for allergic/atopic responses (and parasitic defense); total IgE gives a general sense of allergic burden, allergen-specific IgE identifies what someone is actually reactive to.
Nutrients that move it
- Vitamin Dcontested -- a secondary analysis of the VDKA trial (children with asthma and low vitamin D) tested whether vitamin D3 supplementation lowered total and allergen-specific IgE; results were mixed/not clearly beneficial for IgE itself despite vitamin D's broader immune-modulating effects. A separate systematic review and meta-analysis of 13 RCTs in asthma patients found vitamin D supplementation had no significant effect on serum IgE at study endpoint, though it did raise anti-inflammatory IL-10. (cite: VDKA secondary analysis, Journal of Allergy and Clinical Immunology, 2021, PMC8655021; meta-analysis of 13 RCTs, PMC10965564)
Food first: There is no nutrient supplement with solid evidence for lowering IgE directly; standard allergy/asthma management (allergen avoidance, medical therapy) remains the evidence-based approach, with vitamin D sufficiency as reasonable general immune support rather than an IgE-lowering intervention.
When to see someone: Don't market vitamin D or any supplement as an "IgE reducer" -- the best trial evidence specifically on this endpoint is null or mixed.
Read the studies on Immunoglobulin E (IgE), Total and Allergen-SpecificThyroid Peroxidase (TPO) and Thyroglobulin (Tg) Antibodies
Cellular Six: SenseThis marker sits in Sense -- signals being produced, detected and acted on.
The antibodies that flag autoimmune thyroid disease (Hashimoto's thyroiditis, Graves' disease) -- see `Labs/Panels/Thyroid.md` for the full micronutrient breakdown, since this is where the strongest nutrient-antibody evidence in the entire autoimmune space lives.
Food first: See Thyroid.md -- selenium sufficiency (time-limited, not indefinite) is the most evidence-backed lever specifically for these antibodies.
When to see someone: Selenium's antibody-lowering effect fades with long-term use in some trials and should be periodically reassessed, not taken indefinitely at high doses; see Thyroid.md for the full safety discussion including selenosis risk.
Read the studies on Thyroid Peroxidase (TPO) and Thyroglobulin (Tg) AntibodiesCeliac Serology -- tTG-IgA, Deamidated Gliadin Peptide (DGP)/Anti-Gliadin, Total IgA
Tissue transglutaminase IgA (tTG-IgA) is the first-line screening test for celiac disease, an autoimmune reaction to gluten that damages the small intestine; total IgA is run alongside it because tTG-IgA is falsely low/negative in people with selective IgA deficiency; deamidated gliadin peptide (DGP) antibodies (largely replacing the older, less specific "anti-gliadin" test) are used as an alternative, especially in IgA-deficient patients and young children, where tTG-IgA sensitivity is lower.
Food first: A confirmed celiac diagnosis is managed with strict gluten elimination, full stop -- this is one of the few places in functional/integrative nutrition where the dietary intervention itself is the guideline-level standard of care, not an adjunct.
When to see someone: Always run total IgA alongside tTG-IgA. In someone with IgA deficiency, a "negative" celiac screen is not a true negative.
Read the studies on Celiac Serology -- tTG-IgA, Deamidated Gliadin Peptide (DGP)/Anti-Gliadin, Total IgAIntrinsic Factor Antibody and Parietal Cell Antibody (Pernicious Anemia)
Antibodies seen in autoimmune (pernicious) anemia, one of the most common causes of true vitamin B12 deficiency in adults -- intrinsic factor antibodies block the protein needed to absorb B12 in the gut; parietal cell antibodies attack the stomach cells that make both intrinsic factor and stomach acid.
Nutrients that move it
- Vitamin B12solid -- B12 deficiency from pernicious anemia is managed with B12 replacement (typically injectable/high-dose oral or sublingual, since intrinsic-factor-dependent gut absorption is impaired), not by "curing" the underlying autoimmune attack on parietal cells or intrinsic factor. (cite: NIH ODS Vitamin B12 Health Professional Fact Sheet)
Food first: Once diagnosed, B12 repletion via a route that bypasses the intrinsic-factor absorption step (IM injection, high-dose oral B12 which has a small intrinsic-factor-independent absorption pathway, or sublingual) is the standard, evidence-based approach.
When to see someone: Pernicious anemia is a lifelong condition requiring ongoing B12 monitoring/repletion, and it raises long-term risk of gastric carcinoid tumors and gastric cancer due to chronic atrophic gastritis -- this needs gastroenterology follow-up (periodic endoscopic surveillance in some cases), not just a B12 supplement.
Read the studies on Intrinsic Factor Antibody and Parietal Cell Antibody (Pernicious Anemia)